World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ChiCTR
Last refreshed on: 9 July 2018
Main ID:  ChiCTR1800016968
Date of registration: 2018-07-05
Prospective Registration: Yes
Primary sponsor: Qilu Hospital of Shandong University
Public title: A prospective study on the effect of different antiosteoporosis drugs on patients after lumbar fusion surgery
Scientific title: A prospective study on the effect of different antiosteoporosis drugs on patients after lumbar fusion surgery
Date of first enrolment: 2018-07-15
Target sample size: C:40;A:40;B:40;
Recruitment status: Recruiting
URL:  http://www.chictr.org.cn/showproj.aspx?proj=28803
Study type:  Interventional study
Study design:  Randomized parallel controlled trial  
Phase:  Other
Countries of recruitment
China
Contacts
Name: Le Li   
Address:  107 Wenhua Road West, Jinan, Shandong, China 250012
Telephone: +86 18560082563
Email: qiluhosp_orthoplee@163.com
Affiliation:  Qilu Hospital of Shandong University
Name: Haipeng Si   
Address:  107 Wenhua Road West, Jinan, Shandong, China 250012
Telephone: +86 18560082571
Email: 18560082571@163.com
Affiliation:  Qilu Hospital of Shandong University
Key inclusion & exclusion criteria
Inclusion criteria: Patients of osteoporosis with lumbar spinal stenosis
Exclusion criteria: 1. Pregnant or lactating woman; 2. Patients with serious cardial, hepatic or renal disease; 3. Patients having envolved in another clinical trials; 4. Patients don't want to attend this research or observe the blind method of this research; 5. Patients unsuitable for this trial for other reasons evaluated by researchers.

Age minimum: 20
Age maximum: 80
Gender: Both
Health Condition(s) or Problem(s) studied
Osteoporosis with lumbar spinal stenosis
Intervention(s)
C:Lumbar Fusion Surgery+Basic anti-osteoporosis drugs;A:Lumbar Fusion Surgery+MenatetrenoneSoft Capsules;B:Lumbar Fusion Surgery+Teriparatide acetate;
Primary Outcome(s)
Japanese orthopeadic association score;Bone mineral density;Lumbar CT;
Secondary Outcome(s)
Visual analogue scale;The oswestry disability index;VIT-D;N-MIDOs;ß-CROSS;T-P1NP;UCOC;Lumbar X-ray;
Secondary ID(s)
Source(s) of Monetary Support
Nothing to declare
Secondary Sponsor(s)
Ethics review
Status: Not approved
Approval date: 26/08/2013
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history